References
- N. D. Yeomans, Management of peptic ulcer disease not related to Helicobacter, J. Gastroenterol. Hepatol.17 (2002) 488-494; DOI: 10.1046/j.1440-1746.2002.02726.x.
- K. G. Kumar and L. Karpagaselvi, Determination of cimetidine in pure form and in dosage forms using N,N-dibromodimethylhydantoin, Analyst119 (1994) 1375-1376; DOI: 10.1039/AN9941901375.
- M. Ayad, A. Shalaby and E. J. M. Hisham, Potentiometric determination of famotidine in pharmaceutical formulations, J. Pharm. Biomed. Anal.29 (2002) 247-254; DOI: 10.1016/S0731-7085(02)00024-9.
- J. Novakovic, High-performance thin-layer chromatography for the determination of ranitidine hydrochloride and famotidine in pharmaceuticals, J. Chromatogr. A.846 (1999) 193-198; DOI: 10.1016/S0021-9673(99)00510-5.
- C. Ho, H. M. Huang, S. Y. Hsu, C. Y. Shaw and B. L. Chang, Simultaneous high-performance liquid chromatographic analysis for famotidine, ranitidine HCl, cimetidine, and nizatidine in commercial products, Drug Dev. Ind. Pharm.25 (1999) 379-385; DOI: 10.1081/DDC-100102186.
- A. Zarghi, A. Shafaati, S. M. Foroutan and A. Khoddam, Development of a rapid HPLC method for determination of famotidine in human plasma using a monolithic column, J. Pharm. Biomed. Anal.39 (2005) 677-680; DOI: 10.1016/j.jpba.2005.03.029.
- J. W. Luo and H. H. Q. Chen, Determination of cimetidine in human plasma by use of coupled-flow injection, solid-phase extraction, and capillary zone electrophoresis, Chromatographia53 (2001) 295-300; DOI:10.1007/BF02490427.
- S. A. Wring, K. E. Kilpatrick, J. T. Hutchins, S. M. Witherspoon, B. Ellis, W. Jenner and C. Serabjit-Singh, Shorter development of immunoassay for drugs: application of the novel RIMMS technique enables rapid production of monoclonal antibodies to ranitidine, J. Pharm. Biomed. Anal.19 (1999) 695-707; DOI: 10.1016/S0731-7085(98)00296-9.
- M. M. Badair, M. A. Korany, M. A. Elsayed and O. T. Fahmy, Spectrofluorimetric determination of three pharmaceutical thiocompounds and allopurinol using mercurochrome, Spectrosc. Lett.23 (1990) 161-173; DOI: 10.1080/00387019008054044.
- A. El-Bayomi, A. El-Shanawany, A. El- Sadek and A. Abd El-Sattar, Synchronous spectrofluorimetric determination of famotidine, fluconazole and ketoconazole in bulk powder and in pharmaceutical dosage forms, Spectrosc. Lett.30 (1997) 25-46; DOI: 10.1080/00387019708002587.
- F. A. El-Yazbi, A. A. Gazy, H. M. Mahgoub, M. A. El-Sayed and R. M. Youssef, Spectrophotometric and titrimetric determination of nizatidine in capsules, J. Pharm. Biomed. Anal.31 (2003) 1027-1034; DOI: 10.1016/S0731-7085(02)00699-4.
- A. S. Amin, I. S. Ahmed, H. A. Dessouki and E. A. Gouda, Utility of oxidation-reduction reaction for the determination of ranitidine hydrochloride in pure form in dosage forms and in the presence of its oxidative degradates, Spectrochim. A Mol. Biomol. Spectrosc.59 (2003) 695-703; DOI: 10.1016/S1386-1425(02)00226-3.
- A. S. Amin, S. A. Shama, I. S. Ahmed and E. A. Gouda, Spectrophotometric determination of famotidine through oxidation with N-bromosuccinimide and cerric sulphate, Anal. Lett.35 (2002) 1851-1862; DOI: 10.1081/AL-120013588.
- E. M. Hassan and F. Belal, Kinetic spectrophotometric determination of nizatidine and ranitidine in pharmaceutical preparations, J. Pharm. Biomed. Anal.27 (2002) 31-38; DOI: 10.1016/S0731-7085(01)00473-3.
- A. Z. Abu-Zuhri, R. M. Shubietah and G. M. Badah, Extractional-spectrophotometric determination of famotidine in pharmaceutical preparations, J. Pharm. Biomed. Anal.21 (1999) 459-465; DOI: 10.1016/S0731-7085(99)00139-9.
- M. S. Garcia, M. I. Albero, C. Sánchez-Pedreño and M. S. Abuherb, Spectrophotometric determination of cimetidine in pharmaceuticals and urine using batch and flow-injection methods, J. Pharm. Biomed. Anal.32 (2003) 1003-1010; DOI: 10.1016/S0731-7085(03)00202-4.
- A. E. Gendy, M. G. El-Bardicy and K. M. Loutfy, Stability indicating method for the determination of nizatidine using 3-methyl-2-benzothiazolinone hydrazone, Spectrosc. Lett.34 (2001) 221-234; DOI: 10.1081/SL-100002011.
- G. Saleh, Two selective spectrophotometric methods for the determination of amoxicillin and cefadroxil, Analyst121 (1996) 641-645; DOI: 10.1039/AN9962100641.
- A. Krebs, B. Starczewska, H. Puzanowska-Tarasiewicz and J. Sledz, Spectrophotometric determination of olanzapine by its oxidation with N-bromosuccinimide and cerium(IV) sulfate, Anal. Sci.22 (2006) 829-833; DOI: 10.2116/analsci.22.829.
- N. Rahman and S. N. Hejaz Azmi, Spectrophotometric method for the determination of verapamil hydrochloride in pharmaceutical formulations using N-bromosuccinimide as oxidant, Farmaco59 (2004) 529-536; DOI: 10.1016/j.farmac.2004.02.008.
- B. G. Gowda, J. Seetharamappa and M. B. Melwanki, Indirect spectrophotometric determinaion of propranolol hydrochloride and piroxicam in pure and pharmaceutical formulations, Anal. Sci.18 (2002) 671-674; DOI: 10.2116/analsci.18.671.
- H. F. Askal, I. H. Refaat, I. A. Darwish and M. A. Marzouq, Evaluation of N-bromosuccinimide as a new analytical reagent for the spectrophotometric determination of fluoroquinolone antibiotics, Chem. Pharm. Bull. (Tokyo)55 (2007) 1551-1556; DOI: 10.1248/cpb.55.1551.
- F. Feigl, Spot Tests in Organic Analysis, Elsevier, Amsterdam 1966.
- International Conference of Harmonization of Technical Requirements for Regulation of Pharmaceuticals for Human Use, ICH Harmonize Tripartite Guidance: Validation of Analytical Procedures: Text and Methodology Q2(R1), ICH, London 2005.
- British Pharmacopoeia, Vol. I, Her Majesty's Stationery Office, London 1998.